These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1544618)

  • 1. [Psychopathologic disorders at the onset of Alzheimer's disease].
    Haupt M; Kurz A; Pollmann S; Romero B
    Fortschr Neurol Psychiatr; 1992 Jan; 60(1):3-7. PubMed ID: 1544618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Symptom severity and symptom progression in Alzheimer's disease-- comparison between two cases with early and late onset].
    Haupt M; Kurz A; Pollmann S; Romero B
    Nervenarzt; 1992 Sep; 63(9):561-5. PubMed ID: 1407227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Manifestations of Alzheimer's disease in daily living].
    Kurz A; Haupt M; Hofmeister EM; Pollmann S; Romero B; Ulm K; Zimmer R
    Nervenarzt; 1991 May; 62(5):277-82. PubMed ID: 1865957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spared and impaired abilities in community-dwelling patients entering the severe stage of Alzheimer's disease.
    Gillioz AS; Villars H; Voisin T; Cortes F; Gillette-Guyonnet S; Andrieu S; Gardette V; Nourhashémi F; Ousset PJ; Jouanny P; Vellas B;
    Dement Geriatr Cogn Disord; 2009; 28(5):427-32. PubMed ID: 19907179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropsychological and behavioural assessment in Alzheimer's disease].
    Accorrà D; Mazzarini L; Girardi P; Ruberto A; Kotzalidis GD; Tatarelli R
    Ann Ist Super Sanita; 2004; 40(4):485-93. PubMed ID: 15815116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild cognitive impairment: transition between aging and Alzheimer's disease.
    Petersen RC
    Neurologia; 2000 Mar; 15(3):93-101. PubMed ID: 10846869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of psychopathological components of the onset of Alzheimer's disease].
    Mauri MC; Bravin S; Fabiano L; Invernizzi G
    Minerva Psichiatr; 1995 Dec; 36(4):203-7. PubMed ID: 8721199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between non-cognitive symptoms and functional impairment in Alzheimer's disease.
    Mok WY; Chu LW; Chung CP; Chan NY; Hui SL
    Int J Geriatr Psychiatry; 2004 Nov; 19(11):1040-6. PubMed ID: 15481076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychotic symptoms and Alzheimer's disease].
    Alberca R; Gil-Néciga E; Salas D; Pérez JA; Lozano P
    Neurologia; 2000 Jan; 15(1):8-14. PubMed ID: 10730061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].
    Barth S; Schönknecht P; Pantel J; Schröder J
    Fortschr Neurol Psychiatr; 2005 Oct; 73(10):568-76. PubMed ID: 16217697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
    Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
    Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cognitive reserve on neuropsychologic functioning in Alzheimer's disease type sporadic in subjects of Spanish nationality.
    Sánchez JL; Rodríguez M; Carro J
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):113-22. PubMed ID: 12050474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implicit memory and Alzheimer's disease neuropathology.
    Fleischman DA; Wilson RS; Gabrieli JD; Schneider JA; Bienias JL; Bennett DA
    Brain; 2005 Sep; 128(Pt 9):2006-15. PubMed ID: 15975947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive Performance Test: a new approach to functional assessment in Alzheimer's disease.
    Burns T; Mortimer JA; Merchak P
    J Geriatr Psychiatry Neurol; 1994; 7(1):46-54. PubMed ID: 8192830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of nutritional status on cognitive, functional and neuropsychiatric deficits in Alzheimer's disease.
    Spaccavento S; Del Prete M; Craca A; Fiore P
    Arch Gerontol Geriatr; 2009; 48(3):356-60. PubMed ID: 18448178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater impairment of ability in the divided attention task is seen in Alzheimer's disease patients with depression than in those without depression.
    Nakaaki S; Murata Y; Sato J; Shinagawa Y; Tatsumi H; Hirono N; Furukawa TA
    Dement Geriatr Cogn Disord; 2007; 23(4):231-40. PubMed ID: 17308387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive complaint in mild cognitive impairment and Alzheimer's disease.
    Clément F; Belleville S; Gauthier S
    J Int Neuropsychol Soc; 2008 Mar; 14(2):222-32. PubMed ID: 18282320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.